PGNY (Progyny) Total Operating Expense: $210 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PGNY Progyny Inc PGNY
93 GF Score
Price $28.14
GF Value $28.57
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Progyny Total Operating Expense?

Progyny PGNY -7.02% 93 Total Operating Expense is $210 Mil as of Jun. 2026. GuruFocus rates PGNY with a GF Score™ of 93/100 and a GF Value™ of $28.57 (Fairly Valued). The stock has 2 warning signs investors should review.

Progyny's Total Operating Expense for the three months ended in Jun. 2026 was $49 Mil. Progyny's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was $210 Mil.

Progyny Total Operating Expense Related Terms

Progyny Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Progyny's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Progyny Total Operating Expense Chart

Progyny Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only 79.80 143.98 176.62 185.91 219.21

Progyny Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.62 51.31 61.66 47.69 49.30
PGNY
93GF Score
Progyny Inc PGNY
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Progyny Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $210 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $210 Mil mean?
Progyny (PGNY) has a Total Operating Expense of $210 Mil as of Jun. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Progyny and its competitors.
Is Progyny's Total Operating Expense too high?
Progyny's current Total Operating Expense is $210 Mil. Overall, Progyny has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Progyny's Total Operating Expense compare to CLOV and ALHC?
Progyny's Total Operating Expense of $210 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Plans company?
A good Total Operating Expense depends on the Healthcare Plans industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Progyny and its competitors. Progyny's current Total Operating Expense is $210 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Fairly Valued. The stock's GF Value™ is $28.57, compared to a current price of $28.14 — trading 1.5% below its estimated fair value. The current Total Operating Expense is $210 Mil. Progyny's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Progyny (PGNY), the current Total Operating Expense is $210 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Progyny (PGNY) Overvalued in 2026?

Based on GuruFocus' analysis, Progyny stock appears to be undervalued. The current stock price of $28.14 is trading 1.5% below its estimated GF Value™ of $28.57. GuruFocus considers Progyny to be Fairly Valued.

Key valuation signals for PGNY:

  • Total Operating Expense: $210 Mil
  • GF Value™: $28.57 vs. price of $28.14 (1.5% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Progyny Business Description

Address 1359 Broadway, New York, NY, USA, 10018
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
93GF Score

Get the complete analysis for PGNY

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.14
Price
$28.57
GF Value